REGENERON
Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcuta... neous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.
REGENERON
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
1988-01-01
Address:
Tarrytown, New York, United States
Country:
United States
Website Url:
http://www.regeneron.com
Total Employee:
5001+
Status:
Active
Contact:
+118557343648
Total Funding:
8.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager WordPress Content Delivery Network Domain Not Resolving
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-04-19 | Checkmate Pharmaceuticals | Checkmate Pharmaceuticals acquired by Regeneron | 250 M USD |
Investors List
U.S. Department of Health & Human Services
U.S. Department of Health & Human Services investment in Post-IPO Equity - Regeneron
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-17 | Vyriad | Regeneron investment in Series B - Vyriad | 29.5 M USD |
| 2020-06-09 | DNAnexus | Regeneron investment in Series G - DNAnexus | 100 M USD |
| 2019-09-02 | Adicet Bio | Regeneron investment in Series B - Adicet Bio | 80 M USD |
| 2019-04-08 | Alnylam Pharmaceuticals | Regeneron investment in Post-IPO Equity - Alnylam Pharmaceuticals | 800 M USD |
| 2018-06-19 | Decibel Therapeutics | Regeneron investment in Series C - Decibel Therapeutics | 55 M USD |
Newest Events participated
Official Site Inspections
http://www.regeneron.com Semrush global rank: 341.1 K Semrush visits lastest month: 176.15 K
- Host name: 209.235.68.11
- IP address: 209.235.68.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Regeneron"
Regeneron Pharmaceuticals - Wikipedia
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.The company was founded in 1988. [2] Originally focused on neurotrophic factors and their regenerative … See details»
About Regeneron | Our Company
Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization Jun 20 Dupixent ® (dupilumab) Approved in the U.S. as the … See details»
Meet our Leadership Team - Regeneron Pharmaceuticals
Marion McCourt joined Regeneron in 2018 and serves as executive vice president and head of the commercial organization. Prior to joining Regeneron, Ms. McCourt worked at Axovant, a … See details»
Regeneron Locations | Offices Across the Globe
15,100+ employees in 12 countries. More than 15,100 of our colleagues work across the globe, with offices in 12 countries and clinical trials underway in more than 50 countries. See details»
Making Our Medicines | Regeneron
In 2018, Regeneron committed to invest up to $800 million and create 1,500 new full-time jobs in the greater Capital Region by the end of 2024. Since 2014, Regeneron has invested more than $1 billion to transform a vacant former … See details»
Regeneron Announces First-of-its-Kind Donation Matching …
1 day ago Initiative aims to expand and encourage philanthropy to help patients with retinal diseases afford their medications. TARRYTOWN, N.Y., June 24, 2025 (GLOBE NEWSWIRE) … See details»
Regeneron Pharmaceuticals Org Chart + Executive …
See the executive team of Regeneron Pharmaceuticals and its org chart, featuring 101 leaders like Leonard Schleifer, Chris Fenimore and Christina Chan . Toggle navigation The Official Board. Search. Search. Search by segment. … See details»
Regeneron - Leadership Team - The Org
The Leadership Team at Regeneron Pharmaceuticals is responsible for guiding the strategic direction and operational execution of the company. Comprising senior executives from … See details»
Our Locations - We're expanding our reach.
Working at Regeneron We are a team of original thinkers who work together to create life-transforming medicines for people with serious diseases. Whether it's in the laboratory or at lunch, our company is built on breakthrough ideas, … See details»
Regeneron Announces First-of-its-Kind Donation Matching
1 day ago Regeneron uses its media and investor relations website and social media outlets to publish important information about the Company, including information that may be deemed … See details»
Investor Relations | Regeneron Pharmaceuticals Inc.
2 days ago Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Learn more … See details»
Our Teams - Building great things. Together. - Regeneron Careers
Regeneron Genetics Center (RGC) Research & Preclinical Development (R&pD) (51 open vacancies) I work with Regeneron because the company is full of opportunity but more … See details»
Canada - Regeneron Careers
Regeneron is a global biotechnology company that invents life-transforming medicines for people with serious diseases. Founded in 1988, Regeneron is still run by physician-scientists Len … See details»
Regeneron Corporate Presentation
Feb 4, 2025 Regeneron's filings with the U.S. Securities and Exchange Commission. A more complete description of these and other material risks can be found in Regeneron's filings with … See details»
Environmental Sustainability | Regeneron
In addition to our Responsibility Report, we disclose select environmental, social and governance (ESG) information to CDP, a global environmental disclosure not-for-profit organization. We … See details»
Inclusion & Culture | Regeneron
At Regeneron, we are driven by a strong sense of purpose. Fostering a culture of inclusion of different opinions is core to our mission, our culture and our commitment to patients. Our … See details»
Regeneron Announces First-of-its-Kind Donation Matching …
1 day ago TARRYTOWN, N.Y., June 24, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the launch of a pioneering … See details»
Regeneron CIO on balancing biotech innovation with regulatory …
Jun 4, 2025 Founded in 1988 Regeneron is a $14.2 billion US based biotech company employing 15,000 people across 30 countries. ... How did you envision and then structure the … See details»
The Future of Medicine is unscripted. - Regeneron Careers
Working at Regeneron We are a team of original thinkers who work together to create life-transforming medicines for people with serious diseases. Whether it's in the laboratory or at … See details»
Regeneron Pharmaceuticals Launches $200 Million Donation
1 day ago Regeneron Pharmaceuticals has launched a donation matching program for the non-profit organization Good Days, supporting its Retinal Vascular and Neovascular Disease Fund. See details»